Mortality Estimates Favor Annual Mammography From Age 40

This article originally appeared here.
Share this content:
Mortality Estimates Favor Annual Mammography From Age 40
Mortality Estimates Favor Annual Mammography From Age 40

MONDAY, Aug. 21, 2017 (HealthDay News) -- An annual screening mammogram starting at age 40 is the optimal strategy to avert an early breast cancer death, according to a study published online Aug. 21 in Cancer.

R. Edward Hendrick, Ph.D., a radiology professor at the University of Colorado School of Medicine in Denver, and colleagues used computer modeling to assess the three major mammogram recommendations: annual screening from age 40 to 84; annual screening at ages 45 to 54, then every other year from 55 to 79; or every other year from 50 to 74. The authors estimated how many lives would be saved if every U.S. woman born in 1960 followed one of the three recommendations each year.

The researchers found that deaths from breast cancer would decrease by an average of 39.6 percent with annual screenings from 40 to 84. By comparison, breast cancer mortality would decline 30.8 percent with screening until age 79, and 23.2 percent with every-other-year mammography from 50 to 74. The number of lives saved from breast cancer would be 29,369 with annual screening from age 40 to 84; and 22,829 and 17,153, respectively, for the other two recommendations.

"If a woman wants to maximize her chances of averting an untimely breast cancer death," Hendrick told HealthDay, "she should start screening at age 40 and continue screening annually until her life expectancy is less than five to seven years."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Amount of Opioids Prescribed After Hospital Discharge Varies

Amount of Opioids Prescribed After Hospital Discharge Varies

45.6 percent of patients using no opioids 24 hours predischarge were prescribed opioids at discharge

Observation Care Cost Saving in Commercially-Insured Patients

Observation Care Cost Saving in Commercially-Insured Patients

Total, out-of-pocket spending considerably lower for observation care; both increased from '09 to '13

Disrupted Sleep Linked to Increased Amyloid- Production

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

is free, fast, and customized just for you!

Already a member?

Sign In Now »